Harvard University
Demystifying the migraine
Michael Moskowitz, Harvard Medical School professor of neurology, has made multiple discoveries that have revolutionized thinking about migraines, deepened knowledge about why some treatments work, and led to new treatments that are available and prescribed now.
Uncovering Epstein-Barr’s connection to multiple sclerosis
Harvard researchers published a landmark study confirming the Epstein-Barr virus as the leading cause of multiple sclerosis, and found that healthy diets in midlife may benefit long-term cognitive health.
Reversing the course of ALS
Merit Cudkowicz, a Harvard Medical School professor of neurology, co-authored a paper on a new drug that can radically slow and even reverse the course of the disease in a small subset of patients with a rare genetic variant.
Dementia and Alzheimer’s
Recent findings are demystifying Alzheimer's disease
Radcliffe Institute for Advanced Study’s Next in Science series brought experts together to discuss current Alzheimer’s research and explore potential breakthroughs in the future.
Recent findings are demystifying Alzheimer's diseaseEnvironmental exposures are associated with Alzheimer’s disease and dementia
Approaching Alzheimer’s from three different angles
Optimism may lower the risk of developing dementia
A common sleep drug may be linked to an increased dementia risk
Autism and ADHD
Taking a fresh look at the definition of autism
Ari Ne’eman, assistant professor of health policy and management at the T.H. Chan School of Public Health, says that creating a high-needs autism category risks a return to segregation and neglect—though other subdivisions may make more sense.
Taking a fresh look at the definition of autismUnderstanding how ADHD diagnoses can go wrong
A Harvard study found a spike in ADHD diagnoses on Halloween, highlighting the stakes of cognitive bias in medicine.
Funding foundational autism research
Harvard and Yale researchers were awarded $46 million to map how the brain develops to understand the divergences that occur in children with autism.
Ensuring proper dosage on attention medication
Patients taking a high dose of a prescription amphetamine face more than a five-fold increased risk for developing psychosis or mania, according to Harvard research.
Protecting patients from unnecessary harm
Harvard experts say there is mounting evidence that applied behavior analysis (ABA), a type of therapy for children with autism, is frequently ineffective and often harmful.
